New paper alert🔥! DNA/RNA nanostructures are exciting drug carriers. @Reeeeeese1 and Zhihui reviewed how they interact with cells in vivo! Thanks @MaoPhageGroup for editing this special issue for the 60th birthday of @CUHKofficial in Advanced Materials.
https://t.co/zLrY7bureA
Drug delivery systems can be designed to improve cell therapies! In their new Review, Samir Mitragotri et al discuss the engineering of drug delivery systems at various scales to improve the efficacy of therapeutic cells @SMitragotri@hseas@wyssinstitute
https://t.co/DeudN1xYEu
Drug and Delivery are ‘what’ and ‘how’ of therapeutic products. Without knowing ‘what’, ‘how’ is irrelevant. And without answering ‘how’, ‘what’ is not possible. Check out an overview of the evolution of drug delivery technologies over the years https://t.co/qjomXkidmf
🔥 New paper alert!🔥 Our work on folic acid-conjugated gold nanoparticles for treating renal fibrosis is online @PNASNews. I am indebted to @kwcecilia for her resilience and collaborators Prof. James Lau, @cc_szeto, and my team for support since 2016.
https://t.co/oVxEb5QBYT
Inflamed heart tissue after myocardial infarction can be repaired via an intravascularly infusible degradable matrix that binds to leaky vasculature.
https://t.co/gDyxW5oMZU [N&V]
https://t.co/TaJ3etbVAI [Paper]
CUHK researchers from @CUHKengineering and @CUHKMedicine develop a new #goldnanoparticle, which can downregulate the genes that are linked to epidermis hyperproliferation and inflammation, as a self-therapeutic treatment for #psoriasis. @NanoLetters https://t.co/g9VFfVzxh7
Biomarkers found in blood and urine can potentially provide more information, more easily and frequently, than a tissue biopsy. #Adfeature with @illumina
The key question for developers of SCD therapies is whether +ve effects on acute symptoms will translate into meaningful durable protection against organ damage - it will take time for a clear picture to emerge But some v. good work now underway in what was once a neglected area